Effect of low-protein diet on kidney function in diabetic nephropathy: Meta-analysis of randomised controlled trials

BMJ Open

Volumn 3, Issue 5, 2013, Pages

  Nezu, Uru ^a   Kamiyama, Hiroshi ^b   Kondo, Yoshinobu ^c   Sakuma, Mio ^d   Morimoto, Takeshi ^d   Ueda, Shinichiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Chigasaki Municipal Hospital   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; SERUM ALBUMIN;

ARTICLE; DIABETIC NEPHROPATHY; DIET; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; META ANALYSIS; NUTRITION; PATIENT COMFORT; PATIENT COMPLIANCE; PROTEIN RESTRICTION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84878427989     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002934     Document Type: Article

References (45)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. Retnakaran R, Cull CA, Thorne KI, et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006;55:1832-9.
3. Valmadrid CT, Klein R, Moss SE, et al. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Inter Med 2000;160:1093-100. (Pubitemid 30227018)
4. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999;341:1127-33. (Pubitemid 29466226)
5. Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic nephropathy in the United States and the United Kingdom. J Diabetes Complications 2004;18:18-26. (Pubitemid 38332946)
6. Group UPDSU. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
7. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes -NEJM. http://www.nejm.org/doi/full/10.1056/NEJMoa0802987 (accessed 13 Dec 2012).
8. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy -NEJM. http://www.nejm.org/doi/full/10.1056/ NEJMoa011161 (accessed 13 Dec 2012).
9. Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-62. (Pubitemid 23335891)
10. Molitch ME, DeFronzo RA, Franz MJ, et al. Diabetic nephropathy. Diabetes Care 2003;26(Suppl 1):S94-8. (Pubitemid 36928968)
11. American Diabetes Association. Standards of medical care in diabetes -2013. Diabetes Care 2012;36:S11-66.
12. Pan Y, Guo LL, Jin HM. Low-protein diet for diabetic nephropathy: a meta-Analysis of randomized controlled trials. Am J Clin Nutr 2008;88:660-6.
13. Robertson L, Waugh N, Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev 2007;4: CD002181.
14. Pedrini MT, Levey AS, Lau J, et al. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-Analysis. Ann Intern Med 1996;124:627-32. (Pubitemid 26103836)
15. Koya D, Haneda M, Inomata S, et al. Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial. Diabetologia 2009;52:2037-45.
16. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. BMJ 2009;339:b2535.
17. Seino Y, Nanjo K, Tajima N, et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Diabetol Int 2010;1:2-20.
18. Cochrane Handbook for Systematic Reviews of Interventions. http://handbook.cochrane.org/(accessed 11 Dec 2012).
19. Follmann D, Elliott P, Suh I, et al. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992;45:769-73.
20. Abrams KR, Gillies CL, Lambert PC. Meta-Analysis of heterogeneously reported trials assessing change from baseline. Stat Med 2005;24:3823-44. (Pubitemid 43115733)
21. Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011;64:401-6.
22. Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence -study limitations (risk of bias). J Clin Epidemiol 2011;64:407-15.
23. Narita T, Koshimura J, Meguro H, et al. Determination of optimal protein contents for a protein restriction diet in type 2 diabetic patients with microalbuminuria. Tohoku J Exp Med 2001;193:45-55. (Pubitemid 33607764)
24. Sugimoto T, Kikkawa R, Haneda M, et al. Effect of dietary protein restriction on proteinuria in non-insulin-dependent diabetic patients with nephropathy. J Nutr Sci Vitaminol (Tokyo) 1991;37(Suppl): S87-92.
25. Giordano M, Lucidi P, Ciarambino T, et al. Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients. Diabetologia 2008;51:21-8. (Pubitemid 50003769)
26. Percheron C, Colette C, Astre C, et al. Effects of moderate changes in protein intake on urinary albumin excretion in type I diabetic patients. Nutrition 1995;11:345-9.
27. Walker JD, Bending JJ, Dodds RA, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989;2:1411-15. (Pubitemid 20012057)
28. Pedersen MM, Mogensen CE, Jørgensen FS, et al. Renal effects from limitation of high dietary protein in normoalbuminuric diabetic patients. Kidney Int Suppl 1989;27:S115-21. (Pubitemid 19285087)
29. Hansen HP, Christensen PK, Tauber-Lassen E, et al. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy. Kidney Int 1999;55:621-8. (Pubitemid 29082888)
30. Meloni C, Morosetti M, Suraci C, et al. Severe dietary protein restriction in overt diabetic nephropathy: benefits or risks? J Ren Nutr 2002;12:96-101.
31. Velázquez López L, Sil Acosta MJ, et al. Effect of protein restriction diet on renal function and metabolic control in patients with type 2 diabetes: a randomized clinical trial. Nutr Hosp 2008;23:141-7. (Pubitemid 351879622)
32. Dussol B, Iovanna C, Raccah D, et al. A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy. J Ren Nutr 2005;15: 398-406. (Pubitemid 41405756)
33. Meloni C, Tatangelo P, Cipriani S, et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. J Ren Nutr 2004;14:208-13. (Pubitemid 39360976)
34. Brinkworth GD, Noakes M, Parker B, et al. Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial. Diabetologia 2004;47:1677-86. (Pubitemid 40022401)
35. Hansen HP, Tauber-Lassen E, Jensen BR, et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 2002;62:220-8. (Pubitemid 34754065)
36. Pijls LTJ, De Vries H, Van Eijk JTM, et al. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Eur J Clin Nutr 2002;56:1200-7. (Pubitemid 36124409)
37. Pijls LT, De Vries H, Donker AJ, et al. The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Nephrol Dial Transplant 1999;14:1445-53. (Pubitemid 29241736)
38. Raal FJ, Kalk WJ, Lawson M, et al. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6-mo prospective study. Am J Clin Nutr 1994;60:579-85. (Pubitemid 24313005)
39. Dullaart RP, Beusekamp BJ, Meijer S, et al. Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 1993;16:483-92. (Pubitemid 23046640)
40. Zeller K, Whittaker E, Sullivan L, et al. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991;324: 78-84.
41. Ciavarella A, Di Mizio G, Stefoni S, et al. Reduced albuminuria after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy. Diabetes Care 1987;10:407-13. (Pubitemid 17133601)
42. Brouhard BH, Lagrone L. Effect of dietary protein restriction on functional renal reserve in diabetic nephropathy. Am J Med 1990;89:427-31. (Pubitemid 20365389)
43. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985;27:58-65. (Pubitemid 15130686)
44. Bingham SA. Urine nitrogen as a biomarker for the validation of dietary protein intake. J Nutr 2003;133(Suppl):921S-4.S. (Pubitemid 36262799)
45. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996;49:1774-7. (Pubitemid 26186610)